Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)

Historic Non-Current Deffered Revenue for Organogenesis Holdings (ORGO) over the last 5 years, with Q3 2020 value amounting to $1.1 million.

  • Organogenesis Holdings' Non-Current Deffered Revenue rose 4918.48% to $1.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.1 million, marking a year-over-year increase of 4918.48%. This contributed to the annual value of $1.0 million for FY2019, which is 67846.15% up from last year.
  • Organogenesis Holdings' Non-Current Deffered Revenue amounted to $1.1 million in Q3 2020, which was up 4918.48% from $1.1 million recorded in Q2 2020.
  • Organogenesis Holdings' Non-Current Deffered Revenue's 5-year high stood at $10.8 million during Q4 2016, with a 5-year trough of $74000.0 in Q4 2017.
  • Its 5-year average for Non-Current Deffered Revenue is $4.8 million, with a median of $1.1 million in 2020.
  • In the last 5 years, Organogenesis Holdings' Non-Current Deffered Revenue crashed by 9931.8% in 2017 and then surged by 67846.15% in 2019.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Non-Current Deffered Revenue stood at $10.8 million in 2016, then crashed by 99.32% to $74000.0 in 2017, then skyrocketed by 75.68% to $130000.0 in 2018, then surged by 678.46% to $1.0 million in 2019, then rose by 8.5% to $1.1 million in 2020.
  • Its last three reported values are $1.1 million in Q3 2020, $1.1 million for Q2 2020, and $1.1 million during Q1 2020.